Genetic Technologies Limi... (GENE)
NASDAQ: GENE
· Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM
Genetic Cash Flow Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | -12.02M | -9.56M | -9.56M | -8.61M | -8.61M | -8.71M | -8.71M | -7.13M | -7.13M | -7.48M | -7.48M | -7.08M | -7.08M | -6.93M | -9.57M | -9.4M |
Depreciation & Amortization | 534.89K | 453.86K | 453.86K | 503.38K | 503.38K | 694.28K | 694.28K | 578.67K | 578.67K | 551.69K | 551.69K | 478.22K | 478.22K | 263.85K | 407.05K | 381.57K |
Stock-Based Compensation | 124.18K | 253.45K | 253.45K | 253.45K | 253.45K | 437.51K | 437.51K | 437.51K | 437.51K | 113.31K | 113.31K | 714.58K | 714.58K | 520.56K | 568.77K | 302.6K |
Other Working Capital | 111.98K | -294.15K | -294.15K | -294.15K | -294.15K | 221.18K | 221.18K | 221.18K | 221.18K | -143.83K | -143.83K | -143.83K | -143.83K | 61.82K | 61.82K | -28.68K |
Other Non-Cash Items | 1.83M | 3.42M | 3.42M | 3.58M | 3.58M | 4.52M | 4.52M | 1.66M | 1.66M | 388.27K | 388.27K | -154.65K | -154.65K | -307.61K | -410.65K | 1.66M |
Deferred Income Tax | n/a | -290.96K | -290.96K | -290.96K | -290.96K | 1.07M | 1.07M | 1.07M | 1.07M | -517.02K | -517.02K | -517.02K | -517.02K | 55.41K | 55.41K | 132.98K |
Change in Working Capital | -31.39K | 164.24K | 164.24K | 164.24K | 164.24K | -2.24M | -2.24M | -2.24M | -2.24M | -270.51K | -270.51K | -270.51K | -270.51K | 31.71K | 31.71K | -549.04K |
Operating Cash Flow | -9.56M | -5.69M | -6.72M | -5.55M | -5.55M | -5.25M | -4.22M | -5.62M | -5.62M | -6.7M | -7.79M | -7.39M | -7.39M | -7.7M | -9.51M | -8.12M |
Capital Expenditures | -33.73K | -41K | -41K | -34.11K | -16.11K | -83.91K | -82.91K | -107.79K | -106.79K | -87K | -113K | -194K | -192.45K | -168.03K | -144.55K | -85.6K |
Cash Acquisitions | n/a | -188 | -188 | -375 | -486.38K | -489.19K | -489.19K | -424.96K | -3.4M | -3.4M | -3.4M | -3.46M | n/a | 5.19K | 42.19K | 37K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 43.38K | 43.38K | 43.38K |
Other Investing Acitivies | 147.87K | 118.41K | 118.41K | 79.94K | 79.94K | 190.38K | 190.38K | 46.59K | 46.59K | -58.85K | -58.85K | n/a | n/a | -48.57K | -5.19K | -474.15K |
Investing Cash Flow | -4.08K | -41K | -41K | 45.45K | -422.55K | -382.72K | -381.72K | -486.16K | -3.46M | -3.55M | -3.58M | -3.66M | -192.45K | -168.03K | -64.17K | -505.22K |
Debt Repayment | -172.85K | -509.25K | -509.25K | -502.88K | -502.88K | -166.48K | -166.48K | -15.45K | -15.45K | -9.93K | -9.93K | -109.28K | -109.28K | -114.79K | -214.52K | -99.72K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3M | -66.29K | -918.29K | -916.06K | -916.06K | -1.11M | -253.15K | -269.13K | -269.13K | -489.13K | 7.05M | 6.28M | 6.28M | 21.11M | 17.76M | 20.33M |
Financial Cash Flow | 3.43M | 3.47M | 9.19M | 9.2M | 9.2M | 5.89M | -430.1K | -295.05K | -295.05K | -57.43K | 7.48M | 6.46M | 6.47M | 20.86M | 17.4M | 20.23M |
Net Cash Flow | -6.22M | -6.14M | -1.32M | -3.05M | -3.88M | -868.81K | 7.1M | 7.77M | 6.39M | 3.93M | -2.92M | -2.35M | 2.81M | 15.83M | 10.43M | 10.98M |
Free Cash Flow | -9.6M | -5.73M | -6.76M | -5.58M | -5.56M | -5.34M | -4.31M | -5.73M | -5.73M | -6.79M | -7.9M | -7.59M | -7.59M | -7.87M | -9.65M | -8.21M |